Rising health care costs and pharmaceutical prices in particular are among the main factors that have prompted a steady flow of scholarly and lay press articles about moving from paying for volume to ...

This post kicks off the Health Affairs Blog short series, “Value Assessment: Where Do We Go Post-COVID?” The series explores what we have learned about value assessment and related issues during the ...

There are shortcomings in the ways we have approached value assessment to date, writes the executive director of the Innovation and Value Initiative. Jennifer Bright is the executive director of the ...

To ensure that value assessment accounts for patient needs, we need a better understanding of the outcomes that are most important to patients, write authors from COVIA Health Solutions and the ...